About ELIOS Vision
ELIOS Vision is a company based in Los Angeles (United States) founded in 2019 by Thomas F Neuhann and Richard A Lewis was acquired by Bausch & Lomb in December 2024. ELIOS Vision offers products and services including ELIOS and FIDO Laser Applicator. ELIOS Vision operates in a competitive market with competitors including ViaLase, BELKIN Vision, Radiance Therapeutics and EyeLight, among others.
- Headquarter Los Angeles, United States
- Founders Thomas F Neuhann, Richard A Lewis
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Elios Vision, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Bausch & Lomb
(Dec 11, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ELIOS Vision
ELIOS Vision offers a comprehensive portfolio of products and services, including ELIOS and FIDO Laser Applicator.
CE-marked device for treating glaucoma in adult patients.
Applicator for medical laser applications in healthcare.
People of ELIOS Vision
Unlock access to complete
Leadership Team
3 people
Software Development Team
2 people
Sales and Marketing
1 people
Head Team
1 people
Unlock access to complete
Funding Insights of ELIOS Vision
Investors in ELIOS Vision
ELIOS Vision has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bausch & Lomb.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ophthalmic pharmaceuticals and instruments are developed for eye care.
|
Locked | Locked | Locked |
Investor details for ELIOS Vision
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ELIOS Vision
Investment portfolio details for ELIOS Vision
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ELIOS Vision
Detailed financials for ELIOS Vision
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Elios Vision Comparisons
Peer comparison for ELIOS Vision
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ELIOS Vision
ELIOS Vision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ViaLase, BELKIN Vision, Radiance Therapeutics and EyeLight, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Image-guided femtosecond laser devices for glaucoma treatments are developed.
|
|
| Locked | Locked | Locked |
Laser device for glaucoma treatment developed by BELKIN Vision.
|
|
| Locked | Locked | Locked |
Beta ophthalmic applicator for glaucoma surgery is developed.
|
|
| Locked | Locked | Locked |
Develops patented treatment methods for glaucoma.
|
Detailed competitors of ELIOS Vision
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Elios Vision
Complete news archive for ELIOS Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ELIOS Vision
ELIOS Vision was founded in 2019 and raised its 1st funding round 3 years after it was founded.
ELIOS Vision is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
ELIOS Vision was established in 2019 in Los Angeles, United States, within the medical device sector focused on ophthalmology. An excimer laser-based device known as ELIOS ELT is developed for micro-invasive glaucoma surgery. Intraocular pressure in glaucoma patients is targeted for reduction through this technology. Operations center on advancing eye care treatments in the United States.
ELIOS Vision's top competitors include ViaLase, BELKIN Vision and Radiance Therapeutics.
ELIOS Vision offers ELIOS and FIDO Laser Applicator.
ELIOS Vision has 1 investor. Key investors include Bausch & Lomb.